Science Explorer Interactive view Map
Company · Sunnyvale · United States

Pharmacyclics (United States)

In research, Pharmacyclics (United States) stands highest in Medicine (#11,855 of 17,978 worldwide) and Health Sciences (#15,022 of 20,462 worldwide), over all time.

World rank, all time
#14,363
of 42,892
Rank in United States
#3,136
of 8,685
Research works
229
▼ 54% vs 2013–17
Citations
11k
46.7 per fractional work
Top-10% rate
19.1%
record average 16.5%
Open access
22%
world 28%

What is Pharmacyclics (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #11,855 of 17,978 23.7%123
Health SciencesDomain #15,022 of 20,462 23.7%124

Each strip is that field’s whole ranked pool, with the notch where Pharmacyclics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.38× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.96× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 5.42× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 5.93× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.14× its world share, 0 worksChemistryHealth Professions: 0.08× its world share, 0 worksHealth ProfessionsMedicine: 4.34× its world share, 8 worksMedicineworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 5.9×. Every wedge is a field page.

Who are the top researchers at Pharmacyclics (United States)?

Ranked on the composite score, Richard A. Miller, Joseph J. Buggy and Markus F. Renschler lead among researchers whose main affiliation is Pharmacyclics (United States).

  1. 1 Richard A. Miller United States · #312,524 worldwide 130 citations · 38 works
  2. 2 Joseph J. Buggy United States · #452,846 worldwide 84 citations · 20 works
  3. 3 Markus F. Renschler United States · #488,174 worldwide 42 citations · 19 works
  4. 4 Danelle F. James United States · #1,019,248 worldwide 34 citations · 15 works
  5. 5 Sriram Balasubramanian United States · #1,204,087 worldwide 37 citations · 18 works
All ranked researchers at Pharmacyclics (United States)

Which keywords describe research at Pharmacyclics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Rituximab, Prognostic Factors, Therapeutic Targets, Chronic Lymphocytic Leukemia, Genomic Aberrations, PET Imaging, Reactive Oxygen Species and Lymphoma.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Rituximab52▲ 144×3 topics
  2. Prognostic Factors43▲ 41×10 topics
  3. Therapeutic Targets37▲ 68×4 topics
  4. Chronic Lymphocytic Leukemia35▲ 317×1 topic
  5. Genomic Aberrations35▲ 317×1 topic
  6. PET Imaging22▲ 45×4 topics
  7. Reactive Oxygen Species20▲ 17×7 topics
  8. Lymphoma19▲ 56×3 topics
  9. Nanoparticles18▲ 5.8×7 topics
  10. Classification17▲ 21×2 topics
  11. Genetic Pathogenesis17▲ 124×1 topic
  12. Molecular Profiling17▲ 63×1 topic
  13. Immunotherapy17▲ 11×12 topics
  14. Photodynamic Therapy16▲ 44×3 topics
  15. Cancer Therapy14▲ 9.8×9 topics
  16. Cancer Treatment13▲ 22×5 topics
  17. Antimicrobial10▲ 16×3 topics
  18. Clinical Applications10▲ 57×2 topics
  19. Photosensitizers10▲ 176×1 topic
  20. Singlet Oxygen10▲ 176×1 topic
  21. Metal Complexes10▲ 24×2 topics
  22. Chemotherapy8▲ 5.2×12 topics
  23. Glycosylation8▲ 16×3 topics
  24. Self-Assembly8▲ 8.7×4 topics
  25. Monoclonal Antibodies8▲ 24×3 topics
  26. Therapeutic Antibodies8▲ 26×2 topics
  27. Antibody Engineering8▲ 33×1 topic
  28. Fc Receptors8▲ 33×1 topic
  29. Gene Expression7▲ 5.0×6 topics
  30. Tumor Targeting7▲ 22×3 topics
  31. Targeted Therapy6▲ 13×4 topics
  32. Epigenetic Regulation6▲ 13×3 topics
  33. Fluorescence Imaging6▲ 24×1 topic
  34. Photothermal Therapy6▲ 32×1 topic
  35. Phthalocyanines6▲ 61×1 topic
  36. Porphyrins6▲ 61×1 topic
  37. Anticancer Agents6▲ 11×7 topics
  38. Mutation6▲ 16×3 topics
  39. Transcriptional Regulation6▲ 10×4 topics
  40. HDAC Inhibitors6▲ 128×1 topic

Which research topics does Pharmacyclics (United States) publish most on?

By volume in 2022–2025: Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Radiopharmaceutical Chemistry and Applications and Phagocytosis and Immune Regulation.

  1. 1 Chronic Lymphocytic Leukemia Research Genetics 3 works
  2. 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 2 works
  3. 3 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
  4. 4 Phagocytosis and Immune Regulation Immunology 0 works
  5. 5 Chronic Myeloid Leukemia Treatments Hematology 0 works
  6. 6 HER2/EGFR in Cancer Research Oncology 0 works
  7. 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  8. 8 PI3K/AKT/mTOR signaling in cancer Molecular Biology 0 works
  9. 9 Immunodeficiency and Autoimmune Disorders Immunology 0 works
  10. 10 Acute Lymphoblastic Leukemia research Public Health, Environmental and Occupational Health 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available21.7%not open78.3%

World: 28% of research is openly available.

with international co-authors16.2%domestic only83.8%

World: 19% is written across borders.

How has Pharmacyclics (United States)'s research output changed?

Output in 2018–2022 was 54% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Sunnyvale

All research institutions in Sunnyvale

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.